Atricure, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Atricure, Inc. on February 6, 2008, regarding corporate governance changes. The report details the departure of a principal officer and the subsequent appointment of a replacement effective February 18, 2008.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and contains no financial data.
Material Changes
- Departure: Ms. Elsa Chi Abruzzo, Vice President of Regulatory and Clinical Affairs, tendered her resignation effective February 18, 2008.
- Appointment: Mr. James L. Lucky, previously the Vice President of Quality Assurance and Healthcare Compliance, was appointed Vice President of Regulatory Affairs and Quality Assurance to assume Ms. Abruzzo's duties.
- Background: Mr. Lucky previously held a similar position with the medical segment of Teleflex, Inc.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirm the effective date of Ms. Abruzzo's resignation (February 18, 2008).
- Verify Mr. Lucky's new title and scope of responsibilities as Vice President of Regulatory Affairs and Quality Assurance.
- Review Mr. Lucky's prior experience at Teleflex, Inc. to assess continuity in regulatory and quality functions.